IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 297 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,513,300 | +14.8% | 110,000 | 0.0% | 0.08% | +5.6% |
| Q1 2023 | $3,931,400 | -5.4% | 110,000 | 0.0% | 0.07% | -12.2% |
| Q4 2022 | $4,154,700 | -14.6% | 110,000 | 0.0% | 0.08% | -14.6% |
| Q3 2022 | $4,865,000 | +19.5% | 110,000 | 0.0% | 0.10% | +10.3% |
| Q2 2022 | $4,072,000 | – | 110,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,540,858 | $145,281 | 7.63% |
| Bellevue Group AG | 9,380,300 | $384,873,709 | 5.49% |
| Deep Track Capital, LP | 2,834,069 | $116,281,851 | 5.38% |
| Camber Capital Management LP | 2,500,000 | $102,575 | 3.34% |
| Sicart Associates LLC | 204,947 | $8,408,975 | 3.27% |
| BVF INC/IL | 2,846,015 | $116,771,995 | 3.26% |
| Privium Fund Management B.V. | 226,493 | $9,311,128 | 1.96% |
| Orbimed Advisors | 2,169,500 | $89,014,585 | 1.61% |
| SECTOR GAMMA AS | 160,401 | $6,581,253 | 1.47% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $8,206,000 | 1.21% |